Glucagon-like peptide-1 as predictor of body mass index and dentate gyrus neurogenesis: Neuroplasticity and the metabolic milieu

Neural Plasticity

Volumn 2014, Issue , 2014, Pages

  Coplan, Jeremy D ^a   Syed, Shariful ^b   Perera, Tarique D ^c   Fulton, Sasha L ^c   Banerji, Mary Ann ^d   Dwork, Andrew J ^c,e   Kral, John G ^d  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b Downstate Health Sciences University   (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^d Downstate College of Medicine SUNY DMC   (United States)

^e New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLECORTIN; GLUCAGON LIKE PEPTIDE 1; HIGH DENSITY LIPOPROTEIN; INCRETIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; BIOLOGICAL MARKER;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; CORRELATIONAL STUDY; DENTATE GYRUS; DIABESITY; EPIDEMIC; GROWTH DISORDER; INSULIN RESISTANCE; MACACA RADIATA; MALE; MORPHOMETRICS; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; OBESITY; TRIACYLGLYCEROL BLOOD LEVEL; AGE; ANIMAL; FEMALE; MENTAL STRESS; METABOLISM; PHYSIOLOGY;

AGE FACTORS; ANIMALS; BIOMARKERS; BODY MASS INDEX; DENTATE GYRUS; FEMALE; GLUCAGON-LIKE PEPTIDE 1; INSULIN RESISTANCE; MACACA RADIATA; MALE; NEUROGENESIS; NEURONAL PLASTICITY; STRESS, PSYCHOLOGICAL;

EID: 84916218212     PISSN: 20905904     EISSN: 16875443     Source Type: Journal    
DOI: 10.1155/2014/917981     Document Type: Article

References (29)

1. Kimura K. D., Tissenbaum H. A., Liu Y., Ruvkun G., Daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 1997 277 5328 942 946 10.1126/science.277.5328.942 2-s2.0-0030813398
2. Castro C., Krumsiek J., Lehrbach N. J., Murfitt S. A., Miska E. A., Griffin J. L., A study of Caenorhabditis elegans DAF-2 mutants by metabolomics and differential correlation networks. Molecular BioSystems 2013 9 7 1632 1642 10.1039/c3mb25539e 2-s2.0-84878740669
3. Murphy C. T., Hu P. J., Insulin/insulin-like growth factor signaling in C. elegans. WormBook: The Online Review of C. elegans Biology 2013 1 43
4. Calixto A., Jara J. S., Court F. A., Diapause formation and downregulation of insulin-like signaling via DAF-16/FOXO delays axonal degeneration and neuronal loss. PLoS Genetics 2012 8 12 e1003141 10.1371/journal.pgen.1003141 2-s2.0-84872038812
5. Mortensen K., Christensen L. L., Holst J. J., Orskov C., GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine. Regulatory Peptides 2003 114 2-3 189 196 10.1016/S0167-0115(03)00125-3 2-s2.0-0037784011
6. Turton M. D., O'Shea D., Gunn I., Beak S. A., Edwards C. M. B., Meeran K., Choi S. J., Taylor G. M., Heath M. M., Lambert P. D., Wilding J. P. H., Smith D. M., Ghatei M. A., Herbert J., Bloom S. R., A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 1996 379 6560 69 72 10.1038/379069a0 2-s2.0-13344282056
7. Scott K. A., Moran T. H., The GLP-1 agonist exendin-4 reduces food intake in nonhuman primates through changes in meal size. American Journal of Physiology: Regulatory Integrative and Comparative Physiology 2007 293 3 R983 R987 10.1152/ajpregu.00323.2007 2-s2.0-34548390977
8. Harkavyi A., Whitton P. S., Glucagon-like peptide 1 receptor stimulation as a means of neuroprotection. British Journal of Pharmacology 2010 159 3 495 501 10.1111/j.1476-5381.2009.00486.x 2-s2.0-76449115696
9. Perera T. D., Lu D., Thirumangalakudi L., Smith E. L. P., Yaretskiy A., Rosenblum L. A., Kral J. G., Coplan J. D., Correlations between hippocampal neurogenesis and metabolic indices in adult nonhuman primates. Neural Plasticity 2011 2011 6 875307 2-s2.0-80053577601 10.1155/2011/875307
10. Coplan J. D., Fathy H. M., Abdallah C. G., Reduced hippocampal N-acetyl-aspartate (NAA) as a biomarker for overweight. NeuroImage: Clinical 2014 4 326 335 10.1016/j.nicl.2013.12.014 2-s2.0-84893327796
11. Kaufman D., Banerji M. A., Shorman I., Smith E. L. P., Coplan J. D., Rosenblum L. A., Kral J. G., Early-life stress and the development of obesity and insulin resistance in juvenile bonnet macaques. Diabetes 2007 56 5 1382 1386 10.2337/db06-1409 2-s2.0-34248229213
12. Jackowski A., Perera T. D., Abdallah C. G., Garrido G., Tang C. Y., Martinez J., Mathew S. J., Gorman J. M., Rosenblum L. A., Smith E. L. P., Dwork A. J., Shungu D. C., Kaffman A., Gelernter J., Coplan J. D., Kaufman J., Early-life stress, corpus callosum development, hippocampal volumetrics, and anxious behavior in male nonhuman primates. Psychiatry Research: Neuroimaging 2011 192 1 37 44 10.1016/j.pscychresns.2010.11.006 2-s2.0-79952900821
13. Fulton S. L., Panthangi V., Reiner W., Cisternal CSF 5H1AA inversely predicts hippocampal volume in nonhuman primates (NHP): impact of early life stress (ELS) on serotonin function. Biological Psychiatry 2014 75 9 supplement 1 312S 313S
14. Coplan J. D., Fathy H. M., Jackowski A., Early life stress and macaque amygdala hypertrophy: preliminary evidence for a role for the serotonin transporter gene. Frontiers in Behavioral Neuroscience 2014 8 article 342 10.3389/fnbeh.2014.00342
15. Coplan J. D., Abdallah C. G., Tang C. Y., Mathew S. J., Martinez J., Hof P. R., Smith E. L. P., Dwork A. J., Perera T. D., Pantol G., Carpenter D., Rosenblum L. A., Shungu D. C., Gelernter J., Kaffman A., Jackowski A., Kaufman J., Gorman J. M., The role of early life stress in development of the anterior limb of the internal capsule in nonhuman primates. Neuroscience Letters 2010 480 2 93 96 10.1016/j.neulet.2010.06.012 2-s2.0-77954541515
16. Sleddering M. A., Bakker L. E. H., Janssen L. G. M., Meinders A. E., Jazet I. M., Higher insulin and glucagon-like peptide-1 (GLP-1) levels in healthy, young South Asians as compared to Caucasians during an oral glucose tolerance test. Metabolism: Clinical and Experimental 2014 63 2 226 232 2-s2.0-84892675721 10.1016/j.metabol.2013.10.008
17. Flegal K. M., Carroll D., Kit B. K., Ogden C. L., Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. The Journal of the American Medical Association 2012 307 5 491 497 10.1001/jama.2012.39 2-s2.0-84856487711
18. Mokdad A. H., Ford E. S., Bowman B. A., Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. The Journal of the American Medical Association 2003 289 1 76 79 10.1001/jama.289.1.76 2-s2.0-0037223174
19. Turner R. C., Holman R. R., Matthews D., Hockaday T. D. R., Peto J., Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. Metabolism 1979 28 11 1086 1096 10.1016/0026-0495(79)90146-X 2-s2.0-0018571214
20. Coplan J. D., Altemus M., Mathew S. J., Smith E. L. P., Scharf B., Coplan P. M., Kral J. G., Gorman J. M., Owens M. J., Nemeroff C. B., Rosenblum L. A., Synchronized maternal-infant elevations of primate CSF CRF concentrations in response to variable foraging demand. CNS Spectrums 2005 10 7 530 536 2-s2.0-22844449709
21. Perera T. D., Coplan J. D., Lisanby S. H., Lipira C. M., Arif M., Carpio C., Spitzer G., Santarelli L., Scharf B., Hen R., Rosoklija G., Sackeim H. A., Dwork A. J., Antidepressant-induced neurogenesis in the hippocampus of adult nonhuman primates. The Journal of Neuroscience 2007 27 18 4894 4901 2-s2.0-34247856025 10.1523/JNEUROSCI.0237-07.2007
22. Cohen J., Eta-squared and partial eta-squared in fixed factor ANOVA designs. Educational and Psychological Measurement 1973 33 1 107 112 10.1177/001316447303300111
23. Pierce S. B., Costa M., Wisotzkey R., Devadhar S., Homburger S. A., Buchman A. R., Ferguson K. C., Heller J., Platt D. M., Pasquinelli A. A., Liu L. X., Doberstein S. K., Ruvkun G., Regulation of DAF-2 receptor signaling by human insulin and ins-1, a member of the unusually large and diverse C. elegans insulin gene family. Genes and Development 2001 15 6 672 686 10.1101/gad.867301 2-s2.0-0035868890
24. Isacson R., Nielsen E., Dannaeus K., Bertilsson G., Patrone C., Zachrisson O., Wikström L., The glucagon-like peptide 1 receptor agonist exendin-4 improves reference memory performance and decreases immobility in the forced swim test. European Journal of Pharmacology 2011 650 1 249 255 10.1016/j.ejphar.2010.10.008 2-s2.0-78649745810
25. Salcedo I., Tweedie D., Li Y., Greig N. H., Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders. British Journal of Pharmacology 2012 166 5 1586 1599 10.1111/j.1476-5381.2012.01971.x 2-s2.0-84862748768
26. Nakagawa T., Tsuchida A., Itakura Y., Nonomura T., Ono M., Hirota F., Inoue T., Nakayama C., Taiji M., Noguchi H., Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice. Diabetes 2000 49 3 436 444 10.2337/diabetes.49.3.436 2-s2.0-18144435678
27. Pospisilik J. A., Stafford S. G., Demuth H.-U., Long-term treatment with the dipeptidyl peptidase IV inhibitor P32/98 causes sustained improvements in glucose tolerance, insulin sensitivity, hyperinsulinemia, and β -cell glucose responsiveness in VDF (fa/fa) Zucker rats. Diabetes 2002 51 4 943 950 10.2337/diabetes.51.4.943 2-s2.0-0036228243
28. Moller D. E., New drug targets for type 2 diabetes and the metabolic syndrome. Nature 2001 414 6865 821 827 10.1038/414821a 2-s2.0-0035857020
29. Meier J. J., Gethmann A., Götze O., Gallwitz B., Holst J. J., Schmidt W. E., Nauck M. A., Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans. Diabetologia 2006 49 3 452 458 2-s2.0-33244481977 10.1007/s00125-005-0126-y